Sopharma launches first Bulgarian-made drug on Austrian market

Sopharma launches first Bulgarian-made drug on Austrian market

The Bulgarian pharmaceutical company Sopharma made history by breaking on the Austrian market with a 100 per cent Bulgarian-manufactured drug, Bulgarian media reported on April 29 2010.Traditionally, the German and Austrian markets are considered as two of the most conservative markets in the world, where foreign-made drugs found it difficult to gain approval to be sold on the local markets.The Sopharma drug is called Nivalin and, according to the description on the company's website, was indicated during the convalescence and residual phase of poliomyelitis and is used for treating several other diseases.In Austria however, the drug is registered with the trademark Nivaject.

Cookies Preferences
Choose Type of Cookies You Accept Using


These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.


These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.


These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.